We are live on ! Find out more
GSKH

GSK PLC ADRhedged
GSKH

1 hedge funds and large institutions have $6.99K invested in GSK PLC ADRhedged in 2025 Q2 according to their latest regulatory filings, with 0 funds opening new positions, 1 increasing their positions, reducing their positions, and 1 closing their positions.

New
Increased
Maintained
Reduced
Closed

50% less funds holding

Funds holding: 2 → 1 (-1)

56.24% less ownership

Funds ownership: 57.57% → 1.33% (-56%)

99% less capital invested

Capital invested by funds: $963K → $6.99K (-$956K)

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 1

Holders
1
Holders Change
-1
Holders Change %
-50%
% of All Funds
0.01%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
–
Increased
1
Reduced
–
Closed
1
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
UBS Group
UBS Group
Switzerland
+$5.35K

Top Sellers

Rank Fund Capital Flow
1
GS
GTS Securities
New York
-$961K
Name Holding Trade Value Shares
Change 		Change in
Stake
UBS Group
1
UBS Group
Switzerland
$6.99K +$5.35K +100 +303%
GS
2
GTS Securities
New York
– -$961K -17,238 Closed

GSKH Hedge Fund Activity: Q2 2025 in Review

1 of the 7,598 institutional investors tracked by Wall St. Rank reported a position in GSK PLC ADRhedged (GSKH) for Q2 2025, worth a combined $6.99K — down 99% from $963K a quarter earlier.

Sellers outnumbered buyers: 1 fund closed out of GSKH and 0 opened new positions — a net loss of 1 holder — while 0 trimmed existing stakes and 1 added.

The largest buyer was UBS Group, adding an estimated $5.35K. The largest seller was GTS Securities, exiting entirely with an estimated $961K sold.

  • 1 institutional investor held GSK PLC ADRhedged (GSKH) as of Q2 2025, down from 2 in Q1 2025.
  • Funds reported $6.99K of GSK PLC ADRhedged stock for Q2 2025, down 99% quarter-over-quarter.
  • 0 funds opened new GSK PLC ADRhedged positions in Q2 2025 and 1 closed out, a net change of -1 holder.
  • The largest GSK PLC ADRhedged buyer in Q2 2025 was UBS Group, an estimated $5.35K added.
  • The largest GSK PLC ADRhedged seller in Q2 2025 was GTS Securities, an estimated $961K sold.

Based on aggregated 13F filings for Q2 2025.